Document is current
Any future updates will be listed below
-
Authors
Gaudet, Veronique https://orcid.org/0000-0002-1285-7453
Turchin, Irina https://orcid.org/0000-0001-8654-9050
Lynde, Charles W.
Kelly, Virginie
Sajic, Dusan
Hassan, Shazia https://orcid.org/0000-0002-3040-9988
Yap, Belinda https://orcid.org/0000-0001-7792-2474
Barakat, Maxime https://orcid.org/0000-0002-3000-2125
Prajapati, Vimal H. https://orcid.org/0000-0002-8315-2522
-
Funding
Funding for this research was provided by:
Bausch Health, Canada Inc.
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 19 February 2025
First Online: 18 March 2025
Declarations
:
: Veronique Gaudet and Maxime Barakat are employees at Bausch Health, Canada Inc. Innomar Strategies, Inc. received consulting fees from Bausch Health, Canada Inc., and is the employer of Belinda Yap and Shazia Hassan. Dr. Irina Turchin has been advisor, consultant, speaker and/or investigator for Abbvie, Amgen, Arcutis, Bausch Health, BMS, Boehringer Ingelheim, Eli Lilly and Company, Galderma, Incyte, Janssen, Kiniksa, LEO Pharma, Mallinckrodt, Novartis, Pfizer, Sanofi Genzyme, Sun Pharma, and UCB. Dr. Charles W. Lynde has been a speaker and/or consultant to: AbbVie, Amgen, Aralez, Arcutis, Bausch Health, Bayer, Bioderma, BioJAMP, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, CeraVe, Cipher, Dermavant, Eli Lilly, Fresnius Kabi, Galderma, GSK, InCyte, Innovaderm, InCyte, Intega Skin, Janssen, Kyowa Kirin, La Roche Posay, LEO Pharma, L’Oreal, Medexus, MedX, Merck, Naos, Novartis, P&G, Pediapharm, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sandoz, Sentrex, SkinCeuticals, SunPharma, Takeda, TEVA, Tribute, UCB, Valeant, Viatris, Volo Health. Dr. Charles W. Lynde has been a principal investigator for: AbbVie, Acelyrin, Akros, Altius, Amgen, Aralez, Arcutis, Avillion, Bausch Health, Bioderma, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Cipher, Concert, Dermavant, Devonian, Eli Lilly, Evelo, Galderma, GSK, InCyte, InCyte, Innovaderm, Intega Skin, Janssen, Kyowa Kirin, La Roche Posay, LEO Pharma, L’Oreal, Medexus, MedX, Merck, MoonLake, Naos, Nimbus, Novartis, P&G, Pediapharm, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sandoz, Sentrex, SunPharma, Takeda, TEVA, Tribute, UCB, Valeant, Viatris, Volo Health. Dr. Virginie Kelly has been advisor, consultant, speaker and/or investigator for: AbbVie, Allakaos, Amgen, Appolo, Aslan pharmaceuticals, Bausch Health, Cara, ConCERT pharmaceuticals, Galderma, GSK, Horizon, Incyte, Inmagene, Innovaderm, Janssen, Laroche-Posay, Leo pharma, Lily, L’Oréal, Nektar, Novartis, Numab, Opsidio, Pfizer, RAPT, Sanofi, Sun pharma, UCB, Verasci. Dr. Dusan Sajic has been advisor, consultant, speaker and/or investigator for: Abbvie, Actilion, Bausch Health, Concert, Derma Research Group, Galderma, Jassen, Leo, Lilly, Novartis, Sun Pharma, UCB. Dr. Vimal H. Prajapati has been an advisor, consultant, speaker, and/or investigator for AbbVie, Actelion, Amgen, AnaptysBio, Apogee Therapeutics, Aralez, Arcutis, Arena, Asana, Aspen, Bausch Health/Valeant, Boehringer Ingelheim, BMS, Celgene, Cipher, Concert, CorEvitas, Dermavant, Dermira, Eli Lilly and Company, Galderma, GSK, Homeocan, Incyte, Janssen, Johnson & Johnson, LEO Pharma, Medexus, Nektar Therapeutics, Nimbus Lakshmi, Novartis, Organon, Pediapharm, Pfizer, RAPT Therapeutics, Regeneron, Reistone, Sanofi Genzyme, Sun Pharma, Takeda, Tribute, UCB, and Vyne Therapeutics.
: Patient consent to use data for analysis was obtained at the time of enrollment into the PSP, and only non-identifiable patient data were collected and analyzed in this study.
